(Q40455103)

English

Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction.

scientific article published on January 2007

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction. (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Epstein–Barr virus

0 references

1 reference

based on heuristic

inferred from title

5

object named as

Annika Linde

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

author name string

Amelie Kinch

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Gunnar Oberg

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Johan Arvidson

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Kerstin I Falk

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Karlis Pauksens

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

publication date

1 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

39

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

235-244

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

describes a project that uses

polymerase chain reaction

1 reference

based on heuristic

inferred from title

EBV persistence in memory B cells in vivo.

1 reference

https://api.crossref.org/works/10.1080%2F00365540600978906

21 January 2018

Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies

1 reference

https://api.crossref.org/works/10.1080%2F00365540600978906

21 January 2018

Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases

1 reference

https://api.crossref.org/works/10.1080%2F00365540600978906

21 January 2018

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1080%2F00365540600978906

21 January 2018

Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting

1 reference

https://api.crossref.org/works/10.1080%2F00365540600978906

21 January 2018

Active Epstein-Barr virus infection after allogeneic stem cell transplantation: re-infection or reactivation?

1 reference

https://api.crossref.org/works/10.1080%2F00365540600978906

21 January 2018

New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors

1 reference

https://api.crossref.org/works/10.1080%2F00365540600978906

21 January 2018

B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome

1 reference

https://api.crossref.org/works/10.1080%2F00365540600978906

21 January 2018

Increased incidence of EBV-related disease following paediatric stem cell transplantation with reduced-intensity conditioning

1 reference

https://api.crossref.org/works/10.1080%2F00365540600978906

21 January 2018

Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease

1 reference

https://api.crossref.org/works/10.1080%2F00365540600978906

21 January 2018

Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1080%2F00365540600978906

21 January 2018

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT.

1 reference

https://api.crossref.org/works/10.1080%2F00365540600978906

21 January 2018

Evaluation of use of Epstein-Barr viral load in patients after allogeneic stem cell transplantation to diagnose and monitor posttransplant lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1080%2F00365540600978906

21 January 2018

Epstein-Barr virus associated disease following blood or marrow transplant

1 reference

https://api.crossref.org/works/10.1080%2F00365540600978906

21 January 2018

Post-transplant lymphoproliferative disorder: a review

1 reference

https://api.crossref.org/works/10.1080%2F00365540600978906

21 January 2018

Detection of Epstein-Barr virus, but not human herpesvirus 8, DNA in cervical secretions from Swedish women by real-time polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1080%2F00365540600978906

21 January 2018

Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma

1 reference

https://api.crossref.org/works/10.1080%2F00365540600978906

21 January 2018

Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy.

1 reference

https://api.crossref.org/works/10.1080%2F00365540600978906

21 January 2018

The real-time polymerase chain reaction-guided modulation of immunosuppression enables the pre-emptive management of Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1080%2F00365540600978906

21 January 2018

High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment.

1 reference

https://api.crossref.org/works/10.1080%2F00365540600978906

21 January 2018

B-cell lymphoproliferative syndrome and peripheral blood CD20+ cells expansion after hematopoietic stem cell transplantation: association with fludarabine and anti-thymocyte globulin containing conditioning regimen.

1 reference

https://api.crossref.org/works/10.1080%2F00365540600978906

21 January 2018

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

1 reference

https://api.crossref.org/works/10.1080%2F00365540600978906

21 January 2018

Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects

1 reference

https://api.crossref.org/works/10.1080%2F00365540600978906

21 January 2018

Late cytomegalovirus disease in marrow transplantation is predicted by virus load in plasma

1 reference

https://api.crossref.org/works/10.1080%2F00365540600978906

21 January 2018

Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients

1 reference

https://api.crossref.org/works/10.1080%2F00365540600978906

21 January 2018

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1080%2F00365540600978906

21 January 2018

Chimaeric anti-CD20 monoclonal antibody (rituximab) in post-transplant B-lymphoproliferative disorder following stem cell transplantation in children.

1 reference

https://api.crossref.org/works/10.1080%2F00365540600978906

21 January 2018

Prognostic factors in patients with post-transplant lymphoproliferative disorders (PTLD) in the rituximab era.

1 reference

https://api.crossref.org/works/10.1080%2F00365540600978906

21 January 2018

Identifiers

10.1080/00365540600978906

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40455103&oldid=1877487613"